Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 300.49 | 260.77 | 155.38 | 0.00 |
Depreciation/ Depletion | 73.24 | 62.54 | 42.12 | - |
Non- Cash Items | 24.46 | 21.75 | 10.30 | - |
Changesin Working Capital | -181.83 | -94.95 | -251.50 | 0.00 |
Cashfrom Operating Activities | 216.35 | 250.12 | -43.70 | 0.00 |
Capital Expenditures | -198.79 | -119.66 | -141.15 | - |
Other Investing Cash Flow Items Total | -15.78 | -38.15 | 2.41 | - |
Cashfrom Investing Activities | -214.56 | -157.80 | -138.74 | - |
Financing Cash Flow Items | -17.21 | -21.05 | -11.96 | - |
Total Cash Dividends Paid | -18.13 | -18.13 | 0.00 | - |
Issuance( Retirement)of Debt Net | 45.06 | -124.29 | 272.34 | - |
Cashfrom Financing Activities | 9.72 | -163.46 | 260.38 | - |
Net Changein Cash | 11.51 | -71.15 | 77.94 | 0.00 |
Cash Interest Paid | 17.21 | 21.05 | 11.96 | - |
Cash Taxes Paid | 56.94 | 62.38 | 21.13 | - |
Aarti Pharmalabs Dividend Aarti Pharmalabs Bonus Aarti Pharmalabs News Aarti Pharmalabs AGM Aarti Pharmalabs Rights Aarti Pharmalabs Splits Aarti Pharmalabs Board Meetings Aarti Pharmalabs Key Metrics Aarti Pharmalabs Shareholdings Aarti Pharmalabs Profit Loss Aarti Pharmalabs Balance Sheet Aarti Pharmalabs Q1 Results Aarti Pharmalabs Q2 Results Aarti Pharmalabs Q3 Results Aarti Pharmalabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks